Citadel Advisors’s Intercure INCR Stock Holding History

Citadel Advisors’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,600	Closed	-$2.24K	–	13729
2025 Q1	$2.24K	Sell	1,600 -6,500	-80%	-$10.5K	﹤0.01%	14054
2024 Q4	$13K	Buy	8,100 +5,200	+179%	+$8.18K	﹤0.01%	13474
2024 Q3	$5.83K	Sell	2,900 -2,700	-48%	-$5.67K	﹤0.01%	13460
2024 Q2	$11.3K	Buy	5,600 +4,800	+600%	+$13K	﹤0.01%	13046
2024 Q1	$2.17K	Sell	800 -5,600	-88%	-$9.53K	﹤0.01%	14034
2023 Q4	$8.19K	Sell	6,400 -3,500	-35%	-$4.27K	﹤0.01%	13239
2023 Q3	$15.6K	Buy	9,900 +9,200	+1,314%	+$14.7K	﹤0.01%	12818
2023 Q2	$1.19K	Sell	700 -100	-13%	-$219	﹤0.01%	13970
2023 Q1	$1.63K	Sell	800 -200	-20%	-$601	﹤0.01%	14266
2022 Q4	$3.3K	Buy	+1,000	New	+$4.63K	﹤0.01%	14231

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Citadel Advisors's INCR Position: Q1 2026 in Review

Citadel Advisors increased its Intercure (INCR) stake by 102% in Q1 2026, buying an estimated $59K and bringing the position to 133,919 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #12020.

Citadel Advisors first reported a position in INCR in Q3 2021 and has held it in 19 quarters since. The position peaked at $206K in Q4 2021. 15 funds tracked by Wall St. Rank hold INCR as of Q1 2026.

Citadel Advisors held 133,919 shares of Intercure worth $101K as of Q1 2026.
Citadel Advisors bought 67,666 Intercure shares in Q1 2026, an estimated $59K.
Intercure made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12020 holding.
Citadel Advisors first reported a position in Intercure in Q3 2021 and has held it in 19 quarters since.
Citadel Advisors's Intercure position peaked at $206K in Q4 2021.
15 funds tracked by Wall St. Rank held Intercure as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.